Novel Anti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALL
Clinical trial NCT05639179 · UNKNOWN
Trial details
- NCT number
- NCT05639179
- Sponsor
- 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-05
- Primary completion
- 2024-12-31
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.